Literature DB >> 26064350

Assessment of the effect of ketamine on cytochrome P450 isoforms activity in rats by cocktail method.

Feiou Lin1, Yan He2, Likang Zhang2, Meiling Zhang3, Yuan Zhang3, Congcong Wen2.   

Abstract

Cocktail method was used to evaluate the influence of ketamine on the activities of CYP450 isoforms CYP1A2, CYP2D6, CYP3A4, CYP2C19, CYP2C9 and CYP2B6, which were reflected by the changes of pharmacokinetic parameters of six specific probe drugs phenacetin, metroprolol, midazolam, omeprazole, tolbutamide and bupropion, respectively. The experimental rats were randomly divided into two group, control group and ketamine group. The ketamine group rats were given 50 mg/kg ketamine by continuous intragastric administration for 14 days. The mixture of six probes was given to rats through intragastric administration and the blood samples were obtained at a series of time-points through the caudal vein. The concentrations of probe drugs in rat plasma were measured by UPLC-MS/MS. In the experiment for ketamine and control group, there was statistical pharmacokinetics difference for phenacetin, metroprolol, midazolam, omeprazole, tolbutamide and bupropion. Continuous intragastric administration for 14 days could induce the activities of CYP450 isoforms CYP1A2, CYP3A4 and CYP2B6 of rats.

Entities:  

Keywords:  CYP450; UPLC-MS/MS; cocktail; ketamine; rat

Year:  2015        PMID: 26064350      PMCID: PMC4443184     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  16 in total

1.  Effects of an ethanol extract of Brazilian green propolis on human cytochrome P450 enzyme activities in vitro.

Authors:  Kyoko Naramoto; Masashi Kato; Kenji Ichihara
Journal:  J Agric Food Chem       Date:  2014-11-10       Impact factor: 5.279

Review 2.  The human hepatic cytochromes P450 involved in drug metabolism.

Authors:  S A Wrighton; J C Stevens
Journal:  Crit Rev Toxicol       Date:  1992       Impact factor: 5.635

3.  Equine cytochrome P450 2B6--genomic identification, expression and functional characterization with ketamine.

Authors:  L M Peters; S Demmel; G Pusch; J T M Buters; W Thormann; J Zielinski; T Leeb; M Mevissen; A Schmitz
Journal:  Toxicol Appl Pharmacol       Date:  2012-11-07       Impact factor: 4.219

4.  Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice.

Authors:  T Suzuki; H Kato; T Aoki; M Tsuda; M Narita; M Misawa
Journal:  Life Sci       Date:  2000-06-16       Impact factor: 5.037

5.  Reliable high-throughput method for inhibition assay of 8 cytochrome P450 isoforms using cocktail of probe substrates and stable isotope-labeled internal standards.

Authors:  Kazumasa Kozakai; Yasuhiro Yamada; Motoji Oshikata; Taiji Kawase; Etsuko Suzuki; Yukari Haramaki; Hideki Taniguchi
Journal:  Drug Metab Pharmacokinet       Date:  2012-04-10       Impact factor: 3.614

6.  [Improvement of package insert CYP information for prescription drugs marketed in Japan].

Authors:  Mutsuko Hirata-Koizumi; Mitsuo Saito; Tsutomu Urano; Shinji Miyake; Ryuichi Hasegawa
Journal:  Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku       Date:  2005

7.  Assessment of effects of chronic hydrogen sulfide poisoning on cytochrome P450 isoforms activity of rats by cocktail approach.

Authors:  Xianqin Wang; Xiaole Chen; Mengchun Chen; Guoxin Hu; Jianshe Ma; Jianchun Pan; Lufeng Hu; Guanyang Lin
Journal:  Biol Pharm Bull       Date:  2013       Impact factor: 2.233

Review 8.  Ketamine: an introduction for the pain and palliative medicine physician.

Authors:  Tomasz Okon
Journal:  Pain Physician       Date:  2007-05       Impact factor: 4.965

9.  Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes.

Authors:  Youssef Hijazi; Roselyne Boulieu
Journal:  Drug Metab Dispos       Date:  2002-07       Impact factor: 3.922

10.  The effects of H2S on the activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in vivo in rat.

Authors:  Xianqin Wang; Anyue Han; Congcong Wen; Mengchun Chen; Xinxin Chen; Xuezhi Yang; Jianshe Ma; Guanyang Lin
Journal:  Int J Mol Sci       Date:  2013-12-10       Impact factor: 5.923

View more
  1 in total

1.  Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study.

Authors:  Paul Glue; Natalie J Medlicott; Shona Neehoff; Peter Surman; Fred Lam; Noelyn Hung; Cheung-Tak Hung
Journal:  Ther Adv Psychopharmacol       Date:  2020-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.